A nationally recognized, comprehensive program dedicated to the conduct of basic, translational, clinical, and population-based research in advancing the understanding, diagnosis, and treatment of cancer and hematological disorders
Education and Training
Our mission is to train the next generation of cancer researchers and clinical leaders by providing clinical inpatient and outpatient practice education along with research training under the supervision of world-renowned specialists
Internationally recognized for our leadership in the prevention, detection, diagnosis, and treatment of cancer. We are committed to meeting the highest standards of cancer care and providing the most advanced treatments.
Dr. Taofeek Owonikoko
Taofeek Owonikoko, MD, PhD joined the the UPMC Hillman Cancer Center and Department of Medicine as the Chief of the Division of Hematology/Oncology in July 2021. He is the Associate Director for Translational Research and Co-Leader of the Cancer Therapeutics Program at Hillman. Dr. Owonikoko holds the Stanley M. Marks – OHA Endowed Chair in Hematology/Oncology Leadership. He will is a key member of the senior leadership team at Hillman, helping to oversee our translational research, development of novel therapeutics, and expediting efforts to expand our clinical trials across the entire Hillman network. As division chief, he works with the leaders in the department of medicine to identify, cultivate and mentor the next generation of clinical and research leaders in oncology by creating a robust pipeline of training and mentoring programs.
Dr. Owonikoko is a physician-scientist, board-certified in Medical Oncology, Hematology and Internal Medicine with a clinical focus on treating patients with lung cancer. His research interests are in pre-clinical biomarker discovery in lung cancer and other solid tumor types, and translation of promising laboratory findings into clinical trials in collaboration with academic and industry partners. He has received extramural grant funding in support of his laboratory and translational research from the National Institutes of Health, Department of Defense and private foundations.
Dr. Samit Ghosh awarded new NIH-NIDDK R01 for his work on chronic kidney disease associated with sickle cell disorders
Dr. Samit Ghosh has received a new R01 from NIDDK titled “Renal endothelium and the development of chronic kidney disease in sickle cell disorders”. With this funding Dr. Ghosh will study Progressive chronic kidney disease (CKD) associated with intravascular hemolysis...
Spring 2023 Research Highlights
Highlighted Publications Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells. In allogeneic hematopoietic stem cell transplantation, donor αβ T cells attack recipient tissues, causing graft-versus-host disease (GVHD),...
Drs. Davar and Zarour discuss their ongoing work on fecal microbiota transplants to improve response to immunotherapy
Dr. Hassane Zarour and Dr. Diwakar Davar are featured on UPMC Physician Journal discussing their ground breaking clinical trial published in Science and ongoing work on the benefits of fecal microbiota transplants to overcome anti-PD-1 therapy resistance and improve...
Division of Hematology/Oncology
UPMC Cancer Pavilion
5150 Centre Avenue, 5th floor
Pittsburgh, PA 15232
412-648-6575 | Email Us
UPMC Hillman Cancer Center
5115 Centre Avenue
Pittsburgh, PA 15232